BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmied L, Höglund P, Meinke S. Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy. Front Immunol 2021;12:640578. [PMID: 33777033 DOI: 10.3389/fimmu.2021.640578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Marini I, Uzun G, Jamal K, Bakchoul T. Treatment of drug-induced immune thrombocytopenias. Haematologica 2022;107:1264-77. [PMID: 35642486 DOI: 10.3324/haematol.2021.279484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ebermeyer T, Cognasse F, Berthelot P, Mismetti P, Garraud O, Hamzeh-Cognasse H. Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword. Int J Mol Sci 2021;22:7894. [PMID: 34360659 DOI: 10.3390/ijms22157894] [Reference Citation Analysis]
3 Park C, Yun JW. Investigation of Biomarkers Associated with Low Platelet Counts in Normal Karyotype Acute Myeloid Leukemia. IJMS 2022;23:7772. [DOI: 10.3390/ijms23147772] [Reference Citation Analysis]
4 Cheng X, Zhang H, Hamad A, Huang H, Tsung A. Surgery-Mediated Tumor-Promoting Effects on the Immune Microenvironment. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Zhao J, Ye H, Lu Q, Wang K, Chen X, Song J, Wang H, Lu Y, Cheng M, He Z, Zhai Y, Zhang H, Sun J. Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs. J Nanobiotechnology 2022;20:62. [PMID: 35109878 DOI: 10.1186/s12951-022-01270-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Şahin AB, Cubukcu E, Ocak B, Deligonul A, Oyucu Orhan S, Tolunay S, Gokgoz MS, Cetintas S, Yarbas G, Senol K, Goktug MR, Yanasma ZB, Hasanzade U, Evrensel T. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Sci Rep 2021;11:14662. [PMID: 34282214 DOI: 10.1038/s41598-021-94184-7] [Reference Citation Analysis]
7 Cho MS, Lee H, Gonzalez-Delgado R, Li D, Sasano T, Carlos-Alcalde W, Ma Q, Liu J, Sood AK, Afshar-Kharghan V. Platelets Increase the Expression of PD-L1 in Ovarian Cancer. Cancers (Basel) 2022;14:2498. [PMID: 35626102 DOI: 10.3390/cancers14102498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang P, Zhao W, Cao H. Development of a Platelet-Related Prognostic Model for Colorectal Cancer. Front Genet 2022;13:904168. [PMID: 35719389 DOI: 10.3389/fgene.2022.904168] [Reference Citation Analysis]
9 Kuter DJ. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies. Haematologica 2022;107:1243-63. [PMID: 35642485 DOI: 10.3324/haematol.2021.279512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yu X, Li J, Ye L, Zhao J, Xie M, Zhou J, Shen Y, Zhou F, Wu Y, Han C, Qian J, Chu T, Su C. Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy. Transl Lung Cancer Res 2021;10:3782-92. [PMID: 34733628 DOI: 10.21037/tlcr-21-681] [Reference Citation Analysis]
11 Anderson R, Blidner AG, Rapoport BL. Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:676399. [PMID: 34168563 DOI: 10.3389/fphar.2021.676399] [Reference Citation Analysis]
12 Bui S, Mejia I, Díaz B, Wang Y. Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis. Front Cell Dev Biol 2021;9:806482. [PMID: 34957124 DOI: 10.3389/fcell.2021.806482] [Reference Citation Analysis]